Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth

Reproductive Sciences

Volumn 16, Issue 3, 2009, Pages 257-264

  Yellon, Steven M ^a   Ebner, Charlotte A ^a   Elovitz, Michal A ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Collagen; Macrophages; Neutrophils; Parturition; Preterm birth

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIRTH; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOCOMPETENT CELL; MACROPHAGE; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX;

ANIMALS; CERVICAL RIPENING; CERVIX UTERI; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; GESTATIONAL AGE; INFLAMMATION; INJECTIONS, INTRAMUSCULAR; LIPOPOLYSACCHARIDES; MACROPHAGES; MEDROXYPROGESTERONE 17-ACETATE; MICE; NERVE FIBERS; NEUTROPHIL INFILTRATION; PREGNANCY; PREMATURE BIRTH; PROGESTINS;

EID: 60049084395     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108325757     Document Type: Article

References (40)

1. Spong CY Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol. 2007 ; 110: 405-415.
2. Sfakianaki AK, Norwitz ER Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med. 2006 ; 19: 763-772.
3. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003 ; 188: 419-424.
4. Johnson JW, Austin KL, Jones GS, Davis GH, King TM Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med. 1975 ; 293: 675-680.
5. Hartikainen-Sorri AL, Kauppila A., Tuimala R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol. 1980 ; 56: 692-695.
6. Hauth JC, Gilstrap LC III, Brekken AL, Hauth JM The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol. 1983 ; 146: 187-190.
7. Fonseca EB, Celik E., Parra M., Singh M., Nicolaides KH Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007 ; 357: 462-469.
8. Rouse DJ, Caritis SN, Peaceman AM, et al, for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007 ; 357: 454-461.
9. O'Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007 ; 30: 687-696.
10. Facchinetti F., Paganelli S., Comitini G., Dante G., Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha- hydroxyprogesterone caproate. Am J Obstet Gynecol. 2007 ; 196: 453-454.
11. Elovitz MA, Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol. 2006 ; 195: 1004-1010.
12. Romero R., Erez O., Espinoza J. Intrauterine infection, preterm labor, and cytokines. J Soc Gynecol Investig. 2005 ; 12: 463-465.
13. Romero R., Espinoza J., Goncalves LF, Kusanovic JP, Friel L., Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med. 2007 ; 25: 21-39.
14. Elovitz M., Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol. 2004 ; 190: 693-701.
15. Elovitz MA, Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation ? Am J Obstet Gynecol. 2005 ; 193: 1149-1155.
16. Goldenberg RL, Hauth JC, Andrews WW Intrauterine infection and preterm delivery. N Engl J Med. 2000 ; 342: 1500-1507.
17. Yellon SM, Mackler AM, Kirby MA The role of leukocyte traffic and activation in parturition. J Soc Gynecol Investig. 2003 ; 10: 323-338.
18. Mackler AM, Iezza G., Akin MR, McMillan P., Yellon SM Macrophage trafficking in the uterus and cervix precedes parturition in the mouse. Biol Reprod. 1999 ; 61: 879-883.
19. Kirby LS, Kirby MA, Warren JW, Tran LT, Yellon SM Increased innervation and ripening of the prepartum murine cervix. J Soc Gynecol Investig. 2005 ; 12: 578-585.
20. Elovitz MA, Gonzalez J. Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth. J Matern Fetal Neonatal Med. 2008 ; 21: 223-230.
21. Timmons BC, Mahendroo MS Timing of neutrophil activation and expression of proinflammatory markers do not support a role for neutrophils in cervical ripening in the mouse. Biol Reprod. 2006 ; 74: 236-245.
22. Rasband WS ImageJ, U. S. National Institutes of Health. Bethesda, MD ; 1997-2007. Available at: http://rsb.info.nih.gov/ij/.
23. Virgo BB, Bellward GD Serum progesterone levels in the pregnant and postpartum laboratory mouse. Endocrinology. 1974 ; 95: 1486-1490.
24. Abbas AK, Lichtman AH, Pober JS Cellular and Molecular Immunology. Section IV. Philadelphia, PA: WB Saunders Co. ; 2000: 299-302.
25. Fujiwara N., Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005 ; 4: 281-286.
26. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001 ; 19: 683-765.
27. Zhou X., Schmidtke P., Zepp F., Meyer CU Boosting interleukin-10 production: therapeutic effects and mechanisms. Curr Drug Targets Immune Endocr Metabol Disord. 2005 ; 5: 465-475.
28. Siewe L., Bollati-Fogolin M., Wickenhauser C., Krieg T., Muller W., Roers A. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol. 2006 ; 36: 3248-3255.
29. Salminen A., Paananen R., Vuolteenaho R., et al. Maternal endotoxin-induced preterm birth in mice: fetal responses in toll-like receptors, collectins, and cytokines. Pediatr Res. 2008 ; 63: 280-286.
30. Kemp B., Rath W., Winkler M., Reineke T., Beier HM, von Rango U. Is cervical dilatation during parturition at term associated with apoptosis ? J Perinat Med. 2005 ; 33: 137-143.
31. Kettritz R., Wilke S., von Vietinghoff S., Luft F., Schneider W. Apoptosis, proliferation and inflammatory infiltration in ANCA-positive glomerulonephritis. Clin Nephrol. 2006 ; 65: 309-316.
32. Mangan DF, Welch GR, Wahl SM Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol. 1991 ; 146: 1541-1546.
33. Hou FF, Boyce J., Zhang Y., Owen WF Jr. Phenotypic and functional characteristics of macrophage-like cells differentiated in pro-inflammatory cytokine-containing cultures. Immunol Cell Biol. 2000 ; 78: 205-213.
34. Hirsch E., Filipovich Y., Mahendroo M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am J Obstet Gynecol. 2006 ; 194: 1334-1340.
35. Gonzalez JM, Xu H., Elovitz MA Preterm and term cervical ripening: similar or divergent molecular mechanisms? [abstract]. Reprod Sci. 2008 ; 15: 262A.
36. Fuchs AC, Granowitz EV, Shapiro L., et al. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J Clin Immunol. 1996 ; 16: 291-303.
37. Yellon SM, Ebner CA, Sugimoto Y. Parturition and recruitment of macrophages in cervix of mice lacking the prostaglandin F receptor. Biol Reprod. 2008 ; 78: 438-444.
38. Richardson JD, Vasko MR Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther. 2002 ; 302: 839-845.
39. Niissalo S., Hukkanen M., Imai S., Tornwall J., Konttinen YT Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci. 2002 ; 966: 384-399.
40. Defranco EA, O'Brien JM, Adair CD, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007 ; 30: 697-705.